Multiple Sclerosis

Ozanimod Shows Long-Term Safety, Efficacy in Open-Label Extension

September 18, 2020

Article

Along with being generally well tolerated, ozanimod was able to help most patients become relapse free without disability progression.

Asaff Harel, MD: Risk Factors for Severe COVID-19 Infection in Multiple Sclerosis

September 17, 2020

Video

The neurologist at Lenox Hill Hospital detailed the findings of his observational study that looked at patterns of COVID-19 infections in patients with multiple sclerosis.

Jakob Dupont, MD: Phase 1 Data on Cell Therapy for Progressive MS

September 16, 2020

Video

The executive vice president and head of global research and development at Atara Biotherapeutics spoke to the findings of a phase 1 study of the cell therapy ATA188.

Tau Levels May Predict Early Disability, Worse Prognosis in MS

September 15, 2020

Article

Data show that higher CSF tau levels at diagnosis correlated with worse disability independent of age, though no such associations were identified with amyloid-beta.

Rapid Readout: Expert Perspectives on Multiple Sclerosis - Data from the 8th Joint ACTRIMS-ECTRIMS Meeting 2020

September 14, 2020

Video

Experts in multiple sclerosis review top data presented at the 8th joint ACTRIMS-ECTRIMS meeting.

Ponesimod Linked to Low Levels of Disease Activity in Relapsing Multiple Sclerosis

September 14, 2020

Article

No new safety signals were observed in the combined analysis of ponesimod from the phase 2b core study and extension study.